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Tales from the EMR: Does a 21st-century data warehouse facilitate 
clinical research for pancreatic cancer?  
  References 
The importance of an electronic medical record has been 
highlighted for both clinical care and research. In the current 
era, data warehouses and repositories have been established 
to serve the dual function of patient care and investigation.  
The aim of this study is to compare a newly developed 
institutional clinical data warehouse, linked with the hospital 
information system (HIS), to a prospectively maintained 
departmental database.  
 Methods  
∙ A high degree of misclassification may be present if queries 
are based solely on ICD-9-CM diagnosis codes. For that 
reason, careful validation and data cleaning are critical steps 
prior to research use.  
∙ The new HIS-linked system was unable to capture over 
one-third of the patients in the surgical oncology database.  
∙ These results suggest cautious interpretation of national-
level administrative data utilizing ICD-9-CM diagnosis codes.  
∙ Current state-of-the-art data warehouses continue to 
require clinical correlation and validation through traditional 
retrospective mechanisms. 
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  Conclusions 
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Databases 
HIS-Linked Database 
This novel HIS-linked institutional clinical data warehouse 
captures inpatient and outpatient clinical and billing 
information from a pool of over 2 million patients evaluated at 
an academic medical institution and its affiliates, since 1995.  
A cohort was identified; following Institutional Review Board 
approval, demographic and clinical data was obtained.  
  
Surgical Oncology Database 
A manually entered and prospectively maintained surgical 
oncology database of the same institution, tracking 394 
patients since 1999 was also used for analysis. 
 
Data Collection 
Both databases were queried for 9 primary and secondary 
ICD-9-CM discharge diagnosis codes for pancreatic cancer. 
Duplicated patients, and those unique to either dataset, were 
flagged. Patients with diagnosis dates prior to 1999 were 
excluded to allow comparison over the same time period.   
 
Statistical Analysis 
For validation purposes, a 10% random sample of remaining 
patients unique to each dataset underwent manual review of 
medical records including clinic notes, admission/discharge 
notes, diagnostic imaging, and pathology reports. 
1107 patients were identified from the HIS-linked dataset 
with pancreatic neoplasm-associated diagnosis codes 
dating from 1999 to 2009. Of these, 254 (22.9%) were 
captured in both datasets, while 853 (77.1%) were only in 
the HIS-linked dataset (see Figure 1). Patients identified in 
each database had similar age, sex, and racial 
characteristics (see Table 2). Manual review of the 10% 
subset of the HIS-only group demonstrated that 55.6% of 
patients were without identifiable pancreatic pathology, 
suggesting miscoding, while 31.7% had diagnoses 
consistent with pancreatic neoplasm, and 12.7% with 
pseudocyst or pancreatitis (see Figure 2). Of the 394 
patients tracked by surgical oncology, 254 (64.5%) were 
captured in both datasets, while 140 (35.5%) had not been 
captured in the HIS-linked dataset. Manual review of the 
10% subset of the non-captured patients demonstrated 
93.3% with pancreatic neoplasm and 6.7% with 
pseudocyst or pancreatitis. Lastly, a review of the 10% 
subset of the 254 patient overlap demonstrated that 87.5% 
of patients were with pancreatic neoplasm, 8.3% with 
pseudocyst or pancreatitis, and 4.2% without pancreatic 
pathology. 
ICD-9-CM 
Code 
Diagnosis 
157.0 Malignant Neoplasm of Head of Pancreas 
157.1 Malignant Neoplasm of Body of Pancreas 
157.2 Malignant Neoplasm of Tail of Pancreas 
157.3 Malignant Neoplasm of Pancreatic Duct 
157.4 Malignant Neoplasm of Islets of Langerhans 
157.8 
Malignant Neoplasm of other unspecified sites 
of Pancreas 
157.9 
Malignant Neoplasm of Pancreas,  
part unspecified 
211.6 
Benign Neoplasm of Pancreas,  
except Islets of Langerhans 
211.7 Benign Neoplasm of Islets of Langerhans 
Table 1. ICD-9-CM diagnosis codes used in this study.  
Surgical 
Oncology 
Database 
Only 
Both  
Databases 
HIS-Linked 
Database 
Only 
Total 
Patients 
140 254 853 
Age  
(in years) 
64.0 
(SD = 13.9) 
63.0 
(SD = 12.0) 
62.8 
(SD = 15.7) 
Sex 
M 51 (41.1%) 123 (50,0%) 412 (48.7%) 
F 73 (58.9%) 123 (50.0%) 434 (51.3%) 
Race 
White 109 (91.6%) 231 (90.9%) 748 (92.2%) 
Other 10 (8.4%) 23 (9.1%) 63 (7.8%) 
Table 2. Demographic data of the patients identified solely in the surgical 
oncology or HIS-linked databases, as well as those captured in both. 
Edward J. Arous BS, Jillian K. Smith MD, MPH, Sing Chau Ng MS, Jennifer F. Tseng MD, MPH, Theodore P. McDade MD 
University of Massachusetts Medical School, Surgical Outcomes Analysis & Research, Worcester, MA  
Figure 2. Validation analysis by manual review of a randomized 10% 
sample of each subset. 
Figure 1. Patients obtained by ICD-9-CM query in the surgical oncology 
database and HIS-linked database. 
